Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
WILBER, I leave and check back.
My horse is back to .0022.
Do we whip Wilber now?
Giddy up young steed.
Holy Smokes "Hold On Today"
just might be a ride up.
What If the company knows just a little more about the future than we do?
Maybe, just maybe they do?
And they know when they give us a little more information the price wont be at .002.
Maybe 10x .
They are probably NOT cashing in the chips today like many here believe.
JUST MY 2 CENTS WORTH.
If that make sense.
Smart
It would make sense that they are hot on the tails of government funding also.
They secured the funding yesterday to get them threw the lag time.
The Government is always late and mountains of paperwork.
They can use only the cash they need and hopefully wait for the Government funding.
IMHO
Added @ .0021
M2Bio-Discovery Centre for AI-Driven Phytomedicine Research: Update
Press Release | 09/13/2023
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / September 13, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in alternative plant-based cannabinoids, medical psilocybin, and cutting-edge mental health therapeutic research driven by artificial intelligence (AI), is pleased to present a groundbreaking update on its latest scientific endeavor:
M2Bio Sciences endeavors to usher in a paradigm shift within the realm of medical health by focusing on the foundational facet of drug discovery. Historically, pharmaceutical development has been indispensable in addressing various medical conditions, from combating bacterial pathogens to mitigating cardiovascular diseases. However, the drug discovery process has been characterized by exorbitant costs, protracted timelines, and ethical considerations involving animal and human trials. In light of the maturation of artificial intelligence, particularly in the domain of general AI, M2Bio posits that this process can be substantially expedited and rendered more cost-effective, with minimal ethical implications, through the utilization of machine learning (ML) models and mature general AI algorithms.
M2Bio Sciences has appointed Ze-ev Krein, an interdisciplinary scientist, and M2Bio Scientific Advisory Board Chairman, to spearhead this pioneering research initiative. Mr. Krein possesses a unique blend of expertise encompassing drug discovery, computer science, and legal background, which includes familiarity with compliance and the legal intricacies associated with drug research and discovery.
Krein, under the tutelage of Prof. Maharaj at the University of Pretoria, will conduct research that contributes both to M2Bio's drug discovery program and to his doctorate, focusing on the most advanced applications of AI in drug discovery. M2Bio will retain the intellectual property and commercial rights for the lead compounds, while the center will actively collaborate with numerous institutions and researchers to foster progress through open-source and joint venture collaborations. Updates on research progress will be periodically disseminated through M2Bio's various media channels.
M2Bio Sciences continues to make substantial investments in AI, which constitutes a fundamental pillar of the company's holistic health approach. The primary application of AI within this framework is as follows:
#1 Drug Discovery Advancement: Artificial Intelligence (AI) harnesses the capacity to scrutinize extensive datasets for the purpose of discerning potential drug candidates. Machine learning models have the capability to prognosticate molecular interactions with precise biological targets, thereby expediting the process of unearthing compounds imbued with therapeutic potential. This facet of AI proves particularly instrumental during target identification and lead optimization phases.
#2 Drug Repurposing Excellence: AI scrutinizes established pharmaceutical agents and their well-documented mechanisms of action, affording the capacity to uncover novel therapeutic utilities for these compounds. This invaluable function not only economizes valuable time and resources but also enables the repurposing of existing agents to treat diverse maladies.
#3 Proficiency in Predicting Drug Toxicity: AI models demonstrate proficiency in anticipation of potential drug toxicity by means of an exhaustive analysis of chemical structures and biological data. The early identification of toxic compounds within the developmental trajectory averts the considerable costs and setbacks associated with late-stage failures.
#4 Precision in Clinical Trial Optimization: AI stands as a powerful tool in the optimization of clinical trial design, adept at identifying apt patient cohorts, forecasting patient responses, and contributing to the formulation of more streamlined and cost-effective clinical trials. This orchestration leads to expeditious drug approval processes.
#5 Excellence in Drug Manufacturing: AI is pivotal in enhancing drug manufacturing processes, ensuring consistent product quality, and diminishing production costs. AI's predictive capabilities also safeguard against manufacturing issues that may precipitate batch failures.
#6 Foretelling Drug Interaction and Adverse Events: AI, through its analysis of patient data, possesses the capacity to predict potential drug interactions and foresee adverse events, thereby empowering healthcare professionals to make judicious and informed treatment determinations.
#7 Pioneering Drug Target Identification: AI adeptly navigates through extensive biological datasets, facilitating the identification of innovative drug targets, a crucial component in developing therapeutics designed to address hitherto refractory diseases.
#8 Innovating Drug Delivery Systems: AI is pivotal in designing avant-garde drug delivery systems, thereby enhancing drug efficacy and concurrently reducing deleterious side effects.
#9 Tailored Medicine Through AI: AI's analytical prowess extends to the personalization of drug regimens, drawing from patient-specific data, including genetic information, in a field referred to as pharmacogenomics. This tailored approach augments treatment outcomes while mitigating adverse reactions.
#10 Regulatory Compliance via AI: AI lends a helping hand to pharmaceutical enterprises in assuring adherence to stringent regulatory standards throughout the drug development process. This proactive involvement mitigates the risk of approval delays.
#11 Strategic Drug Pricing and Market Access: AI leverages its analytical capabilities to scrutinize comprehensive market data, pricing structures, and patient outcomes, providing invaluable insights for shaping drug pricing strategies and determining market access approaches.
#12 Insights Through Drug Data Mining: AI mines vast reservoirs of scientific literature, clinical trial data, and patient records to unearth novel insights that have the potential to inform and shape drug development strategies.
#13 Automation in Drug Discovery: AI-driven robotic systems stand at the vanguard of innovation in automating high-throughput compound screening for drug discovery, thereby ushering in a substantial enhancement in the efficiency of this pivotal process.
The potential applications of AI in drug discovery are virtually boundless. M2Bio leverages nature's wealth to expedite discovery, specifically the synthesis of natural products. While synthesizing natural products poses significant challenges, plants have co-evolved with human organisms, yielding many complex bioactive molecules. Accordingly, M2Bio plans to harness various African plants, known for their biologically active compounds, to identify potential phytochemicals or lead compounds for pharmaceutical development. M2Bio has made substantial financial commitments to the University of Pretoria, a prestigious institution in the South African capital, to extract and characterize these compounds. M2Bio will establish and manage a comprehensive database of these lead compounds, with extraction conducted at its newly established research laboratory at the University: M2Bio-Discovery Centre for AI-Driven Phytomedicine Research. AI algorithms will be employed to expedite the characterization and identification process exponentially. This pioneering initiative represents a significant milestone for Africa.
"Embarking on this scientific journey, we stand at the precipice of a profound transformation in drug discovery. Leveraging the formidable capabilities of artificial intelligence to decode the intricate language of nature found within the compounds of African flora, we are pioneering a path that promises to revolutionize pharmaceutical research and underscores the vital importance of ecological partnerships in scientific innovation. This endeavor embodies a fusion of cutting-edge AI technology and the wisdom of natural ecosystems, marking a scientifically paramount milestone in our quest to advance human health." said Ze-ev Krein.
Jeff Robinson, Chairman and CEO of M2Bio Sciences, added: "Our Team, vision, and mission continue to get stronger and stronger each and every day. It's incredibly rewarding to provide the tools to all the team members at M2Bio Sciences and watch them grow daily."
About Institute of Biomedical Research Corp./ DBA M2Bio Sciences
Institute of Biomedical Research Corp is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids, medical psilocybin and mental health therapeutic research powered by artificial intelligence, and evidence-based sustainable products and solutions that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx™, Medspresso™, Liviana™ brands as well as artificial intelligence-powered nutrition products and solutions under the M2Biome brand. In addition, our research and clinical trials with psilocybin are aimed at new therapies to help patients suffering from alcohol addiction, mental illness, and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies such as artificial intelligence.
The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol "MRES".
Publicly traded Company (OTC Pink:MRES)
www.m2bio.co
jeff@m2bio.co
+27 72 333 2148
Find M2Bio™ on social media
Facebook: M2Bio
Instagram: M2bio.Sciences
LinkedIn: M2Bio
Twitter: @M2bio
DLOC is simmering.
PR of tech progress will make us scream and shout.
Soon.
Fantastic end of day today.
Also. Vietnam.
HyFi and its sister company WPP Energy, have executed a tri party Memorandum of Understanding with Dong Do JSC. DD JSC is an International investment promotion company formed by the Vietnam Government for projects of many state-owned companies and prestigious corporations in Vietnam. The MOU is titled “Comprehensive Cooperation of Investment and Development Strategy in Vietnam”. HyFi and WPP have been invited to create and arrange important outcomes in the developing nation of Vietnam. As such HyFi and WPP have received an exclusive initial priority project list to develop renewable energy, infrastructure and other important projects consistent with the UN’s 17 SDG’s in the following provinces:
Hà N?i
Ninh Thu?n
Ðà N?ng
Khánh Hoà
Ð?ng Nai
H? Chí Minh
Bà R?a – Vung Tàu
C?n Tho
Cà Mau
The initial project list has an expected development cost of approximately $33B
The Vietnam government recognizes the potential for a ‘green industrial revolution’ to boost domestic economic growth, employment and the people’s standard of living. Much of the equipment required for these projects will, in due course, be built in Vietnam, making the country an Asian powerhouse for renewable technology.
HyFi and WPP are mobilizing the necessary technology, and arranging for the provision and financing of equipment and services.
From their website. SWEET
South Africa
HyFi has entered a joint venture with POWGEX ENERGY called “POWGEX-HyFi” to build, own and operate renewable electricity generating facilities for the next 45 years in South Africa. HyFi has put together a consortium of banks, investment banks and institutions approved to provide structured project finance for the build out of as much as 300 gigawatts (GW) of utility scale and rooftop solar electricity, wind, green hydrogen production and potentially atmospheric water generation.
The projects are confirmed to be guaranteed by Power Purchase Agreements from established government bodies. In the first year it is contemplated that installations will begin in the in the first half of 2024 for approximately 1 GW of power at a cost of approximately $2.5 Billion per each 1 GW, and subsequent years will target up to 6 GW of installed capacity, per year, with the help of world class OEM’s and leaders in the renewable energy industry such as large co-developers and EPC’s.
HyFi is in the process of arranging the construction financing and subsequent refinancing via bond issuance for these renewable energy facilities and also the OEM, EPC and O&M partners. Several world class infrastructure investment banks, venture capital and infrastructure funds and A rated (or better) insurers have confirmed their interest in participating. In addition one of the world largest solar panel and battery manufacturers as well have expressed interest, as a supplier and co-developer.
Not a Simple chart this time.
SMOKING CHART
https://stockcharts.com/h-sc/ui?s=MRES
You have got the right idea.
DLOC
beautiful end of day.
Crazy selling with our DLOC.
Totally understand and agree.
Don't forget we can still get government funding also.
Fantastic our management is executing perfectly.
DLOC ...Digital Locations Receives Capital Commitment from GHS Investments of up to $10 Million
The Company will use proceeds from the equity credit line to develop its disruptive technology that will deliver high-speed Internet from satellites directly to smartphones all over the world
SANTA BARBARA, CA, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Digital Locations, Inc. (OTCMKTS:DLOC), the developer of a disruptive technology that will deliver high-speed Internet from satellites directly to smartphones all over the world, today announced that it has entered into an Equity Financing Agreement (the “Agreement”) with GHS Investments, LLC (GHS). Pursuant to the Agreement, GHS has agreed to purchase up to $10.0 million in registered common stock, with timing and amounts of the purchases to be determined at the sole discretion of Digital Locations.
The proceeds from the equity credit line will be used in part to further the development of Digital Locations’ disruptive technology that will deliver high-speed Internet from satellites directly to smartphones all over the world.
“This financing from GHS will help accelerate the development of our disruptive technology,” said Rich Berliner, CEO of Digital Locations. “We appreciate the confidence that GHS has placed in us.”
GHS is a private investment and management group providing financial solutions for high-potential small-cap enterprises.
For further information regarding the terms and conditions of GHS’s investment commitment, see the Company’s 8-K filed with the Securities and Exchange Commission on September 12, 2023.
https://finance.yahoo.com/news/digital-locations-receives-capital-commitment-070100947.html
Yes looks like I did Too
This courtesy fill notification that your trade, has been executed. You bought 168000 shares of DLOC at $0.0026 on 09/12/2023.**
has been executed. You bought 32000 shares of DLOC at $0.0026 on 09/12/2023.**
has been executed. You bought 200000 shares of DLOC at $0.0026 on 09/12/2023.**
has been executed. You bought 57500 shares of DLOC at $0.0029 on 09/12/2023.**
has been executed. You bought 87500 shares of DLOC at $0.0029 on 09/12/2023.**
Simple Chart. Lots of room here to move up.
https://stockcharts.com/h-sc/ui?s=MRES
.023's Almost gone now.
Lets gooo.
DLOC ...Digital Locations Receives Capital Commitment from GHS Investments of up to $10 Million
The Company will use proceeds from the equity credit line to develop its disruptive technology that will deliver high-speed Internet from satellites directly to smartphones all over the world
SANTA BARBARA, CA, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Digital Locations, Inc. (OTCMKTS:DLOC), the developer of a disruptive technology that will deliver high-speed Internet from satellites directly to smartphones all over the world, today announced that it has entered into an Equity Financing Agreement (the “Agreement”) with GHS Investments, LLC (GHS). Pursuant to the Agreement, GHS has agreed to purchase up to $10.0 million in registered common stock, with timing and amounts of the purchases to be determined at the sole discretion of Digital Locations.
The proceeds from the equity credit line will be used in part to further the development of Digital Locations’ disruptive technology that will deliver high-speed Internet from satellites directly to smartphones all over the world.
“This financing from GHS will help accelerate the development of our disruptive technology,” said Rich Berliner, CEO of Digital Locations. “We appreciate the confidence that GHS has placed in us.”
GHS is a private investment and management group providing financial solutions for high-potential small-cap enterprises.
For further information regarding the terms and conditions of GHS’s investment commitment, see the Company’s 8-K filed with the Securities and Exchange Commission on September 12, 2023.
https://finance.yahoo.com/news/digital-locations-receives-capital-commitment-070100947.html
MRES, Thank You, Your making me a believer really really quick.
Maybe get a little PR soon too.
MRES is the #1 holding I have.
About 20%.
I just keep adding near the lows when I have the cash.
I am ready for some new high prices this week.
Chart looks like Crap.
https://stockcharts.com/h-sc/ui?s=XCRT
That Means Turnaround Time is Here.
People loved it at .10
People hate it at .05
Got my rally cap on sideways now.
What has changed except the planned News Never came?
Did I miss something?
1st time adding in a long time @ .053
Post of the day.
Congrats.
We are alive and well.
DLOC
DLOC 8k just out.
Link back for chart.
The Company describes the market research performed by the Florida International University (FIU) tech team
SANTA BARBARA, CA, September 6, 2023 (GLOBE NEWSWIRE) – Digital Locations, Inc. (OTCMKTS:DLOC), the developer of a disruptive technology that will deliver high-speed Internet from satellites directly to smartphones all over the world, today announced the results of the competitive analysis performed by the Florida International University (FIU) tech team.
To better understand the strengths and weaknesses of potential competitors, the FIU tech team undertook an in-depth study of commercially available direct phone to satellite technologies. The results have helped the tech team establish a baseline for performance and system parameters for future systems. The outcome of this study has also helped the tech team identify the specific sub-6 GHz bands and the mmWave bands that will be adopted in its development efforts.
Finally, and of great importance, the market study results assure the FIU tech team that its planned development path is designed to attack real world problems and that it can be reasonably sure there is a market for its proposed technology.
Highlights from the study include:
? There are many satellite connectivity providers available in the market, but in all cases, a dedicated device is a requirement.
? In many cases, only SOS service or text messaging is the only available service.
? Elon Musk’s Starlink can provide high-speed internet using a bulky dish, modem, and AC power supply.
? Hence, direct satellite to mobile using a modified or unmodified smartphone is the best option.
? Many groups are working towards Satellite to Smartphone Technology. However, none appear to be close to delivering high-speed Internet.
“This study performed by the FIU tech team confirms our original thesis,” said Rich Berliner, CEO of Digital Locations. “When we started, we were convinced that no one has yet been able to solve the technical challenges of delivering high-speed Internet from satellites directly to smartphones on a worldwide basis. Now, we are even more certain that is the case. Also, we are confident that the FIU tech team is well positioned to find success.”
About Digital Locations, Inc.
Digital Locations, Inc., is the developer of a disruptive technology that will deliver high-speed Internet from satellites directly to smartphones all over the world. Today, high-speed Internet (also known as broadband Internet) is only available in densely populated areas around the world. The rest of the world is still waiting. Elon Musk (SpaceX), Jeff Bezos (Blue Origin) and others are launching thousands of Low Earth Orbit (LEO) satellites. Unfortunately, without the use of additional equipment, the technology does not yet exist that will allow these satellites to deliver high-speed Internet directly to smartphones. Solving this problem represents an extraordinary business opportunity. Working with a research team from Florida International University, we are developing a truly disruptive technology that will finally make it possible for the wireless industry to offer high-speed Internet service from satellites directly to smartphones anywhere in the world, indoors and outdoors with no dead zones and no cell towers. Anyone, anywhere, regardless of location, economic status, race or gender will be able to access high-speed Internet service and benefit from remote learning, health care, government services, telework, participation in public affairs and even Netflix, Amazon and much, much more.
To learn more about Digital Locations please visit www.digitallocations.com
The Company describes the market research performed by the Florida International University (FIU) tech team
SANTA BARBARA, CA, September 6, 2023 (GLOBE NEWSWIRE) – Digital Locations, Inc. (OTCMKTS:DLOC), the developer of a disruptive technology that will deliver high-speed Internet from satellites directly to smartphones all over the world, today announced the results of the competitive analysis performed by the Florida International University (FIU) tech team.
To better understand the strengths and weaknesses of potential competitors, the FIU tech team undertook an in-depth study of commercially available direct phone to satellite technologies. The results have helped the tech team establish a baseline for performance and system parameters for future systems. The outcome of this study has also helped the tech team identify the specific sub-6 GHz bands and the mmWave bands that will be adopted in its development efforts.
Finally, and of great importance, the market study results assure the FIU tech team that its planned development path is designed to attack real world problems and that it can be reasonably sure there is a market for its proposed technology.
Highlights from the study include:
? There are many satellite connectivity providers available in the market, but in all cases, a dedicated device is a requirement.
? In many cases, only SOS service or text messaging is the only available service.
? Elon Musk’s Starlink can provide high-speed internet using a bulky dish, modem, and AC power supply.
? Hence, direct satellite to mobile using a modified or unmodified smartphone is the best option.
? Many groups are working towards Satellite to Smartphone Technology. However, none appear to be close to delivering high-speed Internet.
“This study performed by the FIU tech team confirms our original thesis,” said Rich Berliner, CEO of Digital Locations. “When we started, we were convinced that no one has yet been able to solve the technical challenges of delivering high-speed Internet from satellites directly to smartphones on a worldwide basis. Now, we are even more certain that is the case. Also, we are confident that the FIU tech team is well positioned to find success.”
About Digital Locations, Inc.
Digital Locations, Inc., is the developer of a disruptive technology that will deliver high-speed Internet from satellites directly to smartphones all over the world. Today, high-speed Internet (also known as broadband Internet) is only available in densely populated areas around the world. The rest of the world is still waiting. Elon Musk (SpaceX), Jeff Bezos (Blue Origin) and others are launching thousands of Low Earth Orbit (LEO) satellites. Unfortunately, without the use of additional equipment, the technology does not yet exist that will allow these satellites to deliver high-speed Internet directly to smartphones. Solving this problem represents an extraordinary business opportunity. Working with a research team from Florida International University, we are developing a truly disruptive technology that will finally make it possible for the wireless industry to offer high-speed Internet service from satellites directly to smartphones anywhere in the world, indoors and outdoors with no dead zones and no cell towers. Anyone, anywhere, regardless of location, economic status, race or gender will be able to access high-speed Internet service and benefit from remote learning, health care, government services, telework, participation in public affairs and even Netflix, Amazon and much, much more.
To learn more about Digital Locations please visit www.digitallocations.com
It will come then we are off to the race upward.
Got to keep buying down here .
Fantastic, Hope its a Knock down can't believe they were able to, PR.
For us shareholders.
MRES
Going green today.
DLOC
Wonderful , Now all in 1 spot.
Very smart, imho
After see this video, Me too.
MRES
Sounds great.. . In the mean time, we all just can wait.
"a little longer"
BOPO